Compare Lupin Ltd with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs WOCKHARDT - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN WOCKHARDT LUPIN/
WOCKHARDT
 
P/E (TTM) x 47.5 -19.5 - View Chart
P/BV x 2.4 1.0 236.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LUPIN   WOCKHARDT
EQUITY SHARE DATA
    LUPIN
Mar-19
WOCKHARDT
Mar-18
LUPIN/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs9861,012 97.4%   
Low Rs720532 135.5%   
Sales per share (Unadj.) Rs369.5355.9 103.8%  
Earnings per share (Unadj.) Rs13.4-60.3 -22.2%  
Cash flow per share (Unadj.) Rs37.4-46.8 -79.9%  
Dividends per share (Unadj.) Rs00.01 0.0%  
Dividend yield (eoy) %00 0.0%  
Book value per share (Unadj.) Rs303.7257.8 117.8%  
Shares outstanding (eoy) m452.49110.63 409.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.32.2 106.5%   
Avg P/E ratio x63.6-12.8 -497.1%  
P/CF ratio (eoy) x22.8-16.5 -138.3%  
Price / Book Value ratio x2.83.0 93.8%  
Dividend payout %00 0.0%   
Avg Mkt Cap Rs m386,06485,379 452.2%   
No. of employees `00017.76.3 282.8%   
Total wages/salary Rs m31,5139,371 336.3%   
Avg. sales/employee Rs Th9,453.86,295.0 150.2%   
Avg. wages/employee Rs Th1,782.01,498.3 118.9%   
Avg. net profit/employee Rs Th343.0-1,066.3 -32.2%   
INCOME DATA
Net Sales Rs m167,18239,369 424.7%  
Other income Rs m3,6401,202 302.8%   
Total revenues Rs m170,82240,571 421.0%   
Gross profit Rs m28,82218 157,498.4%  
Depreciation Rs m10,8501,495 725.6%   
Interest Rs m3,0782,555 120.5%   
Profit before tax Rs m18,534-2,830 -655.0%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,400-3,582 94.9%   
Tax Rs m9,017257 3,508.5%   
Profit after tax Rs m6,066-6,669 -91.0%  
Gross profit margin %17.20 37,088.7%  
Effective tax rate %48.7-9.1 -535.6%   
Net profit margin %3.6-16.9 -21.4%  
BALANCE SHEET DATA
Current assets Rs m138,53633,796 409.9%   
Current liabilities Rs m61,29926,917 227.7%   
Net working cap to sales %46.217.5 264.4%  
Current ratio x2.31.3 180.0%  
Inventory Days Days8479 105.6%  
Debtors Days Days11289 126.0%  
Net fixed assets Rs m127,51639,664 321.5%   
Share capital Rs m905553 163.6%   
"Free" reserves Rs m136,51727,968 488.1%   
Net worth Rs m137,42228,522 481.8%   
Long term debt Rs m66,41721,731 305.6%   
Total assets Rs m279,49481,620 342.4%  
Interest coverage x7.0-0.1 -6,529.9%   
Debt to equity ratio x0.50.8 63.4%  
Sales to assets ratio x0.60.5 124.0%   
Return on assets %3.3-5.0 -64.9%  
Return on equity %4.4-23.4 -18.9%  
Return on capital %8.9-7.7 -116.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m59,4149,807 605.8%   
Fx outflow Rs m22,2821,789 1,245.8%   
Net fx Rs m37,1328,019 463.1%   
CASH FLOW
From Operations Rs m16,660684 2,434.2%  
From Investments Rs m-32,8256,302 -520.8%  
From Financial Activity Rs m7,441-7,695 -96.7%  
Net Cashflow Rs m-8,724-664 1,313.8%  

Share Holding

Indian Promoters % 46.6 74.5 62.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 2.3 491.3%  
FIIs % 31.9 7.7 414.3%  
ADR/GDR % 0.0 0.1 -  
Free float % 10.1 15.4 65.6%  
Shareholders   98,259 67,757 145.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Oct 18, 2019 (Close)

TRACK LUPIN

LUPIN - DR. REDDYS LAB COMPARISON

COMPARE LUPIN WITH

MARKET STATS